Cargando…

Transporter-Mediated Drug–Drug Interactions with Oral Antidiabetic Drugs

Uptake transporters (e.g., members of the SLC superfamily of solute carriers) and export proteins (e.g., members of the ABC transporter superfamily) are important determinants for the pharmacokinetics of drugs. Alterations of drug transport due to concomitantly administered drugs that interfere with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Klatt, Sabine, Fromm, Martin F., König, Jörg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2011
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3857053/ https://www.ncbi.nlm.nih.gov/pubmed/24309303 http://dx.doi.org/10.3390/pharmaceutics3040680

Ejemplares similares

Drug Transport Mechanism of Oral Antidiabetic Nanomedicines
por: Gundogdu, Evren, et al.
Publicado: (2014)

Interaction of Remdesivir with Clinically Relevant Hepatic Drug Uptake Transporters
por: Nies, Anne T., et al.
Publicado: (2021)

Pharmacogenetics of Oral Antidiabetic Drugs
por: Becker, Matthijs L., et al.
Publicado: (2013)

Transport of Drugs and Endogenous Compounds Mediated by Human OCT1: Studies in Single- and Double-Transfected Cell Models
por: Haberkorn, Bastian, et al.
Publicado: (2021)

Nephroprotective Properties of Antidiabetic Drugs
por: Gerdes, Christian, et al.
Publicado: (2023)

Absence of Drug–Drug Interactions Between Luseogliflozin, a Sodium–Glucose Co-transporter-2 Inhibitor, and Various Oral Antidiabetic Drugs in Healthy Japanese Males
por: Sasaki, Takashi, et al.
Publicado: (2015)

Endogenous Biomarkers for SLC Transporter-Mediated Drug-Drug Interaction Evaluation
por: Li, Yang, et al.
Publicado: (2021)

Renal drug transporters and their significance in drug–drug interactions
por: Yin, Jia, et al.
Publicado: (2016)

Drug transporter regulation in tumors by DNA methylation
por: Zolk, Oliver, et al.
Publicado: (2012)

Optimization of a drug transporter probe cocktail: potential screening tool for transporter‐mediated drug–drug interactions
por: Stopfer, Peter, et al.
Publicado: (2018)

Research Methods and New Advances in Drug–Drug Interactions Mediated by Renal Transporters
por: Lin, Kexin, et al.
Publicado: (2023)

Effects of antidiabetic drugs on epicardial fat
por: Xourgia, Eleni, et al.
Publicado: (2018)

Antidiabetic Drugs in the Treatment of Alzheimer’s Disease
por: Michailidis, Michalis, et al.
Publicado: (2022)

Metabolism, Transport and Drug–Drug Interactions of Silymarin
por: Xie, Ying, et al.
Publicado: (2019)

Prediction of Transporter‐Mediated Drug‐Drug Interactions for Baricitinib
por: Posada, Maria M., et al.
Publicado: (2017)

How many oral antidiabetic drugs before insulin?
por: Kelwade, Jayant, et al.
Publicado: (2017)

Drug metabolism and drug transport of the 100 most prescribed oral drugs
por: Iversen, Ditte B., et al.
Publicado: (2022)

Cardiovascular outcomes and safety with antidiabetic drugs
por: Aldossari, Khaled K.
Publicado: (2018)

Pharmacogenetics of new classes of antidiabetic drugs
por: Kadrić, Selma Imamović, et al.
Publicado: (2021)

Drug–drug Interaction between Pravastatin and Gemfibrozil (Antihyperlipidemic) with Gliclazide (Antidiabetic) in Rats
por: Sultanpur, CM, et al.
Publicado: (2010)

Using Positron Emission Tomography to Study Transporter-Mediated Drug–Drug Interactions in Tissues
por: Wulkersdorfer, B, et al.
Publicado: (2014)

Effects of Antidiabetic Drugs on Gut Microbiota Composition
por: Montandon, Sophie A., et al.
Publicado: (2017)

Interactions between antidiabetic drugs and herbs: an overview of mechanisms of action and clinical implications
por: Gupta, Ramesh C., et al.
Publicado: (2017)

Comparative effectiveness of incident oral antidiabetic drugs on kidney function
por: Hung, Adriana M, et al.
Publicado: (2012)

Drug Interactions of Metformin Involving Drug Transporter Proteins
por: Pakkir Maideen, Naina Mohamed, et al.
Publicado: (2017)

Transporter-Mediated Drug Delivery
por: Gyimesi, Gergely, et al.
Publicado: (2023)

Drug–Drug Interactions with Direct Oral Anticoagulants
por: Foerster, Kathrin I., et al.
Publicado: (2020)

Advances in Pharmacokinetic Mechanisms of Transporter-Mediated Herb-Drug Interactions
por: Li, Jie, et al.
Publicado: (2022)

Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents
por: Zhu, Sha, et al.
Publicado: (2022)

Involvement of Transporters in Intestinal Drug–Drug Interactions of Oral Targeted Anticancer Drugs Assessed by Changes in Drug Absorption Time
por: Malnoë, David, et al.
Publicado: (2022)

Crosstalk between gut microbiota and antidiabetic drug action
por: Kyriachenko, Yevheniia, et al.
Publicado: (2019)

Antidiabetic Drugs in NAFLD: The Accomplishment of Two Goals at Once?
por: Tacelli, Matteo, et al.
Publicado: (2018)

The Current Status of New Antidiabetic Drugs
por: Pemminati, Sudhakar, et al.
Publicado: (2016)

Repurposing Antidiabetic Drugs for Cardiovascular Disease
por: Schubert, Mario, et al.
Publicado: (2020)

Effect of Oral Antidiabetic Drugs on Tuberculosis Risk and Treatment Outcomes: Systematic Review and Meta-Analysis
por: Meregildo-Rodriguez, Edinson Dante, et al.
Publicado: (2022)

Adherence to Oral Antidiabetic Drugs in Patients with Type 2 Diabetes: Systematic Review and Meta-Analysis
por: Piragine, Eugenia, et al.
Publicado: (2023)

P-glycoprotein- and organic anion-transporting polypeptide-mediated transport of periplocin may lead to drug–herb/drug–drug interactions
por: Liang, Sheng, et al.
Publicado: (2014)

The Role of Transporters in the Pharmacokinetics of Orally Administered Drugs
por: Shugarts, Sarah, et al.
Publicado: (2009)

Transporter-mediated natural product–drug interactions for the treatment of cardiovascular diseases
por: Zha, Weibin
Publicado: (2017)

Enantioselective Drug Recognition by Drug Transporters
por: Uwai, Yuichi
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_op4b990c826vt6m0tmhbaomcgc